Your browser doesn't support javascript.
loading
Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung.
Shin, Hye Jin; Ku, Keun Bon; Kim, Hae Soo; Moon, Hyun Woo; Jeong, Gi Uk; Hwang, Insu; Yoon, Gun Young; Lee, Sunhee; Lee, Sumin; Ahn, Dae-Gyun; Kim, Kyun-Do; Kwon, Young-Chan; Kim, Bum-Tae; Kim, Seong-Jun; Kim, Chonsaeng.
Affiliation
  • Shin HJ; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Ku KB; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Kim HS; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Moon HW; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Jeong GU; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Hwang I; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Yoon GY; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Lee S; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Lee S; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Ahn DG; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Kim KD; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Kwon YC; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Kim BT; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Kim SJ; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
  • Kim C; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea.
Int J Biol Sci ; 17(14): 3786-3794, 2021.
Article in En | MEDLINE | ID: mdl-34671199
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Virus Attachment / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic_studies Language: En Journal: Int J Biol Sci Year: 2021 Type: Article Affiliation country: South Korea
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Virus Attachment / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic_studies Language: En Journal: Int J Biol Sci Year: 2021 Type: Article Affiliation country: South Korea